The new standards of scientific misconduct; why providers still hesitate to prescribe an addiction treatment

Significant challenges remain before most American clinicians feel comfortable treating patients with buprenorphine. 

July 21, 2023 Check out STAT+

Sponsored By

AP Photo/Alex Brandon STAT+ | White House launches permanent pandemic office The White House on Friday launched its pandemic preparedness office, half a year after Congress instructed the administration to set it up. By Sarah Owermohle STAT+ | Major pharma companies call on their suppliers to reduce carbon footprints Seven of the world's biggest pharma companies are calling on their suppliers to help reduce the drug industry's carbon footprint. By Ed Silverman Opinion: Stanford President Marc Tessier-Lavigne and the new standards of scientific conduct Leaders like Marc Tessier-Lavigne are now accountable for higher research integrity standards than merely not lying about their work. By Lisa M. Rasmussen Elise Amendola/AP Providers still hesitate to prescribe buprenorphine for addiction, despite 'X-waiver' removal Despite the removal of the "X-waiver" for buprenorphine, doctors cite other barriers to medication treatment for opioid addiction. By Lev Facher Misdiagnoses cost the U.S. 800,000 deaths and serious disabilities every year, study finds Diagnostic error of stroke, sepsis, pneumonia, venous thromboembolism, and lung cancer alone caused 300,000 serious harms, including deaths. By Annalisa Merelli STAT+ | European regulator will review study data from contract research organization due to 'serious concerns' The European Medicines Agency is reviewing studies conducted by Synapse Labs, a CRO, due to questions about its study data. By Ed Silverman Greg Nash/Pool via AP STAT+ | FDA official pushes for a dedicated emerging pathogens team to prepare for the next pandemic A top FDA official wants to dedicate full-time staff to emerging pathogens after the agency scrambled to find people for Covid-19 priorities. By Simar Bajaj Europe recommends the approval of Pfizer's RSV vaccine for older adults and in pregnancy European regulators on Friday recommended the approval of Pfizer's RSV vaccine both for older adults and for use in pregnancy. By Andrew Joseph Opinion: Gain-of-function research is about much more than dangerous pathogens Focusing on one type of gain-of-function research has created deep rifts in the life sciences community — and isn't making us safer. By Saskia Popescu and Yong-Bee Lim and Angela Rasmussen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser